Alloclamide

Alloclamide
Clinical data
Trade names	Pectex, Tuselin
Identifiers
	IUPAC name 2-(Allyloxy)-4-chloro-N-[2-(diethylamino)ethyl]benzamide;
CAS Number	5486-77-1 ;
PubChem CID	71837;
ChemSpider	64859;
UNII	H7B263Z7AQ;
KEGG	D01524;
ChEBI	CHEBI:135326;
ChEMBL	ChEMBL2103989;
CompTox Dashboard (EPA)	DTXSID9048853 ;
Chemical and physical data
Formula	C16H23ClN2O2
Molar mass	310.82 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN(CC)CCNC(=O)C1=C(C=C(C=C1)Cl)OCC=C;
	InChI InChI=1S/C16H23ClN2O2/c1-4-11-21-15-12-13(17)7-8-14(15)16(20)18-9-10-19(5-2)6-3/h4,7-8,12H,1,5-6,9-11H2,2-3H3,(H,18,20); Key:UHWFVIPXDFZTFA-UHFFFAOYSA-N;

Alloclamide (Pectex, Tuselin) is an antitussive and antihistamine drug marketed in Finland and Spain. It has never been marketed in the US.

It is sold as an oral solution, containing 6.25 mg/mL alloclamide. The recommended dosage for adults is 25 mg three to four times daily. Adverse effects include constipation and sedation.^[1]

References

^ Schlesser JL (1991). Drugs Available Abroad, 1st Edition. Derwent Publications Ltd. p. 6. ISBN 0-8103-7177-4.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[1] Schlesser JL (1991). Drugs Available Abroad, 1st Edition. Derwent Publications Ltd. p. 6. ISBN 0-8103-7177-4.

[1]